Biological markers for monitoring patient response to VEGF antagonists

Details for Australian Patent Application No. 2010282282 (hide)

Owner GENENTECH, INC.

Inventors Bais, Carlos; Singh, Mallika; Kaminker, Joshua; Brauer, Matthew

Agent Griffith Hack

Pub. Number AU-A-2010282282

PCT Pub. Number WO2011/020049

Priority 61/234,197 14.08.09 US; 61/234,201 14.08.09 US

Filing date 13 August 2010

Wipo publication date 17 February 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020049 Priority application(s): WO2011/020049

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282283-Shared server-side macros

2010282280-Use of IL-15 to increase thymic output and to treat lymphopenia